Koninklijke Philips Past Earnings Performance
Past criteria checks 0/6
Koninklijke Philips's earnings have been declining at an average annual rate of -55.8%, while the Medical Equipment industry saw earnings growing at 12.5% annually. Revenues have been declining at an average rate of 0.7% per year.
Key information
-55.8%
Earnings growth rate
-55.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -0.7% |
| Return on equity | -3.9% |
| Net Margin | -2.6% |
| Next Earnings Update | 03 Feb 2025 |
Recent past performance updates
Recent updates
Philips: Looking Undervalued After Q3 Earnings Drop
Oct 28Philips: Moving Out Of Intensive Care
Oct 09Philips Q2 Earnings: A Focus On Core Strengths Is The Winning Strategy
Jul 29Philips Stock Surges: Risk Remains On Respironics, But With Investment Potential
Jun 28Koninklijke Philips: Major Overhang Removed
May 01Koninklijke Philips: Still On The Cautious Line
Jan 24Philips Q3 Earnings: Getting More Attractive (Rating Upgrade)
Oct 25Koninklijke Philips: Hold For Now
Oct 12Philips: A Healthcare Leader But A Very Risky Investment
Sep 20Revenue & Expenses Breakdown
How Koninklijke Philips makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 18,039 | -469 | 5,127 | 1,724 |
| 30 Jun 24 | 18,133 | -555 | 5,164 | 1,737 |
| 31 Mar 24 | 18,140 | -794 | 5,148 | 1,781 |
| 31 Dec 23 | 18,169 | -456 | 5,153 | 1,890 |
| 30 Sep 23 | 18,529 | -609 | 5,245 | 1,820 |
| 30 Jun 23 | 18,368 | -2,035 | 5,326 | 1,974 |
| 31 Mar 23 | 18,076 | -2,132 | 5,308 | 2,002 |
| 31 Dec 22 | 17,827 | -1,621 | 5,302 | 1,957 |
| 30 Sep 22 | 17,349 | -1,363 | 4,972 | 1,974 |
| 30 Jun 22 | 17,194 | 402 | 4,854 | 1,790 |
| 31 Mar 22 | 17,247 | 491 | 4,785 | 1,776 |
| 31 Dec 21 | 17,156 | 608 | 4,865 | 1,806 |
| 30 Sep 21 | 19,669 | 1,173 | 5,250 | 1,757 |
| 30 Jun 21 | 17,703 | 811 | 4,627 | 1,630 |
| 31 Mar 21 | 19,669 | 1,147 | 5,098 | 1,741 |
| 31 Dec 20 | 17,313 | 991 | 4,564 | 1,691 |
| 30 Sep 20 | 19,492 | 1,142 | 5,094 | 1,724 |
| 30 Jun 20 | 18,327 | 966 | 4,857 | 1,660 |
| 31 Mar 20 | 19,490 | 1,055 | 5,212 | 1,691 |
| 31 Dec 19 | 17,147 | 984 | 4,582 | 1,639 |
| 30 Sep 19 | 19,110 | 1,354 | 5,219 | 1,761 |
| 30 Jun 19 | 18,714 | 1,452 | 5,086 | 1,707 |
| 31 Mar 19 | 18,330 | 1,381 | 5,104 | 1,701 |
| 31 Dec 18 | 18,121 | 1,303 | 5,003 | 1,683 |
| 30 Sep 18 | 17,838 | 1,022 | 4,944 | 1,640 |
| 30 Jun 18 | 17,680 | 871 | 4,915 | 1,676 |
| 31 Mar 18 | 17,687 | 808 | 4,832 | 1,672 |
| 31 Dec 17 | 17,780 | 814 | 4,831 | 1,660 |
| 30 Sep 17 | 17,783 | 830 | 4,754 | 1,731 |
| 30 Jun 17 | 17,792 | 876 | 4,720 | 1,708 |
| 31 Mar 17 | 24,724 | 1,105 | 6,594 | 2,037 |
| 31 Dec 16 | 17,422 | 788 | 4,623 | 1,648 |
| 30 Sep 16 | 19,211 | 218 | 5,435 | 1,741 |
| 30 Jun 16 | 20,890 | 248 | 5,920 | 1,784 |
| 31 Mar 16 | 22,732 | 365 | 6,404 | 1,855 |
| 31 Dec 15 | 16,806 | 145 | 5,121 | 1,562 |
| 30 Sep 15 | 23,685 | 590 | 6,470 | 1,820 |
| 30 Jun 15 | 23,043 | 228 | 6,275 | 1,721 |
| 31 Mar 15 | 22,038 | 191 | 6,001 | 1,638 |
| 31 Dec 14 | 21,391 | 225 | 5,930 | 1,635 |
| 28 Sep 14 | 20,373 | 437 | 5,712 | 1,498 |
| 29 Jun 14 | 20,774 | 839 | 5,742 | 1,575 |
| 30 Mar 14 | 21,437 | 974 | 5,834 | 1,601 |
| 31 Dec 13 | 21,990 | 1,031 | 5,903 | 1,657 |
Quality Earnings: PHG is currently unprofitable.
Growing Profit Margin: PHG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PHG is unprofitable, and losses have increased over the past 5 years at a rate of 55.8% per year.
Accelerating Growth: Unable to compare PHG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PHG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Return on Equity
High ROE: PHG has a negative Return on Equity (-3.93%), as it is currently unprofitable.